Skip to main content

Table 3 Univariate analysis of Ki67 change and clinic-pathological factors

From: Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients

Clinic-pathological factors P value
Age 0.521
Menopause status 0.638
Tumor size 0.658
Lymph node status 0.358
Estrogen receptora 0.529
Progesterone receptora 0.585
HER2a 0.569
Molecular subtypea 0.030
Surgery time interval 0.007
  1. aExpression status in CNB sample
  2. Univariate ANOVA analysis used to analyze association between Ki67 change and clinico-pathological factors